Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

A case of aromatase inhibitor (anastrozole)-induced side-effects successfully treated with Kampo medicines.

Chino A, Okamoto H, Hirasaki Y, Ueda K, Ogawa K, Namiki T.

J Altern Complement Med. 2011 Nov;17(11):1075-7. doi: 10.1089/acm.2010.0536. Epub 2011 Nov 9.

PMID:
22070441
2.

Drug-induced pruritic micropapular eruption: anastrozole, a commonly used aromatase inhibitor.

Bremec T, Demsar J, Luzar B, Pavlović MD.

Dermatol Online J. 2009 Jul 15;15(7):14.

PMID:
19903442
3.

Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women.

Gradishar WJ.

Oncology. 2005;69(1):1-9. Epub 2005 Jul 28. Review.

PMID:
16088229
4.

Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, Mlineritsch B, Tausch C, Stierer M, Hofbauer F, Renner K, Dadak C, Rücklinger E, Samonigg H; Austrian Breast and Colorectal Cancer Study Group.

J Natl Cancer Inst. 2007 Dec 19;99(24):1845-53. Epub 2007 Dec 11. Erratum in: J Natl Cancer Inst. 2008 Feb 6;100(3):226.

PMID:
18073378
5.

Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management.

Altundag K, Dede D, Harputluoglu H, Gullu I.

Joint Bone Spine. 2007 Dec;74(6):662-3. Epub 2007 Aug 13. No abstract available.

PMID:
17913550
6.

Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature.

Lycette JL, Luoh SW, Beer TM, Deloughery TG.

Breast Cancer Res Treat. 2006 Oct;99(3):249-55. Epub 2006 Jun 3. Review.

PMID:
16752073
7.

Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.

Carpenter R.

Eur J Surg Oncol. 2008 Jul;34(7):746-55. doi: 10.1016/j.ejso.2008.01.011. Epub 2008 Mar 4. Review.

PMID:
18296017
8.

The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.

Monnier AM.

Expert Rev Anticancer Ther. 2007 May;7(5):627-34. Review.

PMID:
17492927
9.

Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study.

Briot K, Tubiana-Hulin M, Bastit L, Kloos I, Roux C.

Breast Cancer Res Treat. 2010 Feb;120(1):127-34. doi: 10.1007/s10549-009-0692-7. Epub 2009 Dec 25.

PMID:
20035381
10.

[Effects of anastrozole on lipid metabolism in Chinese postmenopausal women with breast cancer].

Lu HH, Li Q, Xu BH, Zhang P, Yuan P, Wang JY, Cai RG.

Zhonghua Zhong Liu Za Zhi. 2011 Jul;33(7):520-5. Chinese.

PMID:
22093630
11.

Is long-term adjuvant treatment of breast cancer with anastrozole indicated?

Doggrell SA.

Expert Opin Pharmacother. 2008 Jun;9(9):1619-22. doi: 10.1517/14656566.9.9.1619 .

PMID:
18518790
12.

Influence of concurrent anastrozole on acute and late side effects of whole breast radiotherapy.

Valakh V, Trombetta MG, Werts ED, Labban G, Khalid MK, Kaminsky A, Parda D.

Am J Clin Oncol. 2011 Jun;34(3):245-8. doi: 10.1097/COC.0b013e3181df4b62.

PMID:
20622644
13.

[Aromatase inhibitors and arthralgia].

Nagykálnai T, Landherr L, Mészáros E.

Magy Onkol. 2011 Mar;55(1):32-9. doi: MagyOnkol.2011.55.1.32. Epub 2011 Mar 31. Review. Hungarian.

14.

Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?

Moscetti L, Agnese Fabbri M, Sperduti I, Fabrizio N, Frittelli P, Massari A, Pompei L, D'Auria G, Pofi E, Ruggeri EM.

Tumori. 2015 Sep-Oct;101(5):469-73. doi: 10.5301/tj.5000376. Epub 2015 Jun 13.

PMID:
26108239
15.

Aromatase inhibitor-associated arthralgia syndrome.

Burstein HJ.

Breast. 2007 Jun;16(3):223-34. Epub 2007 Mar 21. Review.

PMID:
17368903
16.

Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients.

Sagara Y, Kosha S, Baba S, Dokiya F, Tamada S, Sagara Y, Matsuyama Y, Ohi Y, Ando M, Rai Y, Sagara Y, Douchi T.

Breast Cancer. 2010 Jul;17(3):212-7. doi: 10.1007/s12282-009-0135-7. Epub 2009 Jun 13.

PMID:
19526308
17.

Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trial.

Buzdar A.

Clin Breast Cancer. 2003 Apr;4 Suppl 1:S42-8. Review.

PMID:
12756078
18.

Anastrozole for breast cancer: recent advances and ongoing challenges.

Buzdar AU.

Expert Rev Anticancer Ther. 2006 Jun;6(6):839-48. Review.

PMID:
16761927
19.

Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer.

Kubo M, Onishi H, Kuroki S, Okido M, Shimada K, Yokohata K, Umeda S, Ogawa T, Tanaka M, Katano M.

Anticancer Res. 2012 Jun;32(6):2331-6.

PMID:
22641670
20.

Three years' follow-up from the ATAC trial is sufficient to change clinical practice: a debate.

Aapro MS, Forbes JF.

Breast Cancer Res Treat. 2003;80 Suppl 1:S3-11; discussion S13-8. Review.

PMID:
14535530

Supplemental Content

Support Center